Oxurion NV, an integrated biopharmaceutical company, develops and commercializes medicines for the treatment of eye diseases and cancer in Belgium and internationally. Its lead product is JETREA used for the treatment of symptomatic vitreomacular adhesion and vitreomacular traction. The company also develops THR-149, a plasma kallikrein inhibitor, which is in Phase II clinical trials for the treatment of diabetic macular edema (DME); and THR-687 an integrin antagonist that has completed Phase I clinical trials for the treatment of DME. It has collaboration agreements with Bicycle Therapeutics, Parexel, INC Research, and Galapagos. The company was formerly known as ThromboGenics NV and changed its name to Oxurion NV in September 2018. Oxurion NV was founded in 1991 and is headquartered in Leuven, Belgium.
प्रकार | 5 मिनट | 15 मिनट | प्रति घंटा | दैनिक | मासिक |
|---|---|---|---|---|---|
| मूविंग एवरेज | मजबूत विक्रय | मजबूत विक्रय | मजबूत विक्रय | मजबूत विक्रय | मजबूत विक्रय |
| तकनीकी संकेतक | मजबूत विक्रय | मजबूत विक्रय | मजबूत विक्रय | मजबूत विक्रय | मजबूत विक्रय |
| सारांश | मजबूत विक्रय | मजबूत विक्रय | मजबूत विक्रय | मजबूत विक्रय | मजबूत विक्रय |
नाम | अंतिम | उच्च | निम्न | बदलाव | बदलाव % | वॉल्यूम | समय | ||
|---|---|---|---|---|---|---|---|---|---|
| 4.30 | 4.55 | 4.30 | -0.20 | -4.44% | 11.48M | NSE | |||
| 1,942.15 | 1,975.00 | 1,930.00 | +4.70 | +0.24% | 2.08M | NSE | |||
| 1,749.94995 | 1,795.40002 | 1,736.55005 | -27.40000 | -1.54% | 45.57K | NSE | |||
| 60.15 | 62.95 | 59.05 | -1.20 | -1.96% | 147.66K | BSE | |||
| 506.80 | 517.45 | 505.00 | -7.20 | -1.40% | 12.59M | NSE | |||
| 1,145.75 | 1,225.00 | 1,140.05 | -42.45 | -3.57% | 56.53K | NSE | |||
| 215.20 | 218.70 | 214.90 | -0.15 | -0.07% | 407.10K | BSE | |||
| 242.65 | 251.95 | 239.00 | -1.10 | -0.45% | 2.47M | NSE | |||
| 78.40 | 82.95 | 77.75 | -0.75 | -0.95% | 929.87K | NSE | |||
| 563.90 | 571.30 | 562.60 | -5.70 | -1.00% | 1.18M | NSE | |||
| 81.10 | 85.60 | 80.65 | -1.90 | -2.29% | 162.43K | NSE | |||
| 62.95 | 65.50 | 62.30 | -2.00 | -3.08% | 11.32M | NSE | |||
| 135.45 | 140.30 | 134.25 | -3.85 | -2.76% | 10.45M | NSE | |||
| 1,529.25 | 1,550.90 | 1,523.00 | +7.75 | +0.51% | 6.17M | NSE | |||
| 415.65 | 433.00 | 407.50 | +4.30 | +1.05% | 762.00K | NSE |